Target intelligence / Profile preview

Mitochondrial glutamate carrier 2 (SLC25A18)

Target
SLC25A18
Molecular classification
Transporter, Solute carrier family 25, Mitochondrial carrier protein
01

Overview

Mitochondrial glutamate carrier 2 (SLC25A18) is a mitochondrial inner membrane protein that transports L-glutamate into the mitochondrial matrix in symport with protons. This process is essential for glutamate metabolism in mitochondria, which contributes to ATP generation, ammonia detoxification, and prevention of neuronal excitotoxicity. SLC25A18 is part of the SLC25 family of mitochondrial carriers, which have a conserved structural fold and transport mechanism. Its function is especially relevant in the central nervous system, where it helps regulate neurochemical and metabolic processes. Altered expression or dysfunction of SLC25A18 has been linked to neurodegenerative diseases and white matter disorders, where it contributes to mitochondrial dysfunction, oxidative stress, and neuronal cell death.

Other names
Mitochondrial glutamate carrier 2GC2Glutamate/H(+) symporter 2Solute carrier family 25 member 18GC-2SLC25A18
02

Mechanism of action

Drugs (hypothetically) targeting SLC25A18 would modulate mitochondrial glutamate import or inhibit/protect against glutamate-induced excitotoxicity or mitochondrial dysfunction

03

Biological functions

L-glutamate transport across the inner mitochondrial membraneAmino acid:proton symport activityMitochondrial energy homeostasisRegulation of glutamate metabolismPrevention of excitotoxicityRegulation of neuronal apoptosisATP productionOxidative stress modulation
04

Disease associations

Neurodegenerative disease (including Alzheimer’s disease)Metabolic disorders (e.g., white matter pathology, leukodystrophies)Oxidative stress-related disease
05

Safety considerations

Targeting SLC25A18 may risk disrupting neurotransmitter balanceTargeting SLC25A18 may risk inducing excitotoxicityTargeting SLC25A18 may risk inducing mitochondrial dysfunctionTargeting SLC25A18 may risk inducing apoptosis
06

Biomarkers

SLC25A18 expression may serve as a biomarker for neurodegenerative disorders such as Alzheimer's diseaseSLC25A18 expression may serve as a biomarker for monitoring mitochondrial dysfunction

Beyond the preview

Go deeper on Mitochondrial glutamate carrier 2 (SLC25A18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial glutamate carrier 2 (SLC25A18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call